San Diego, CA, United States of America

Jessica Killian

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Illumina Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jessica Killian. Retrieved from https://idiyas.com/inventor/jessica-killian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jessica Killian: Innovator in Sequencing Polynucleotides

Introduction

Jessica Killian is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the area of sequencing polynucleotides. Her innovative work has the potential to advance genetic research and diagnostics.

Latest Patents

Jessica holds a patent for "Sequencing Polynucleotides Using Nanopores." This groundbreaking technology utilizes nanopore sequencing methods to enhance the accuracy and efficiency of genetic sequencing. Her patent represents a significant advancement in the field and showcases her expertise in biotechnology.

Career Highlights

Jessica is currently employed at Illumina Corporation, a leading company in the field of genomics. Her role at Illumina allows her to work on cutting-edge technologies that are shaping the future of genetic research. Her dedication to innovation has positioned her as a key player in the biotechnology industry.

Collaborations

Jessica collaborates with various professionals in her field, including her coworker Jeffrey G Mandell. These collaborations foster an environment of innovation and creativity, leading to advancements in genetic sequencing technologies.

Conclusion

Jessica Killian is a remarkable inventor whose work in sequencing polynucleotides is paving the way for future advancements in biotechnology. Her contributions to Illumina Corporation and the broader scientific community highlight her commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…